Guardian Pharmacy Services, Inc. (GRDN)
Data as of , from SEC Form 4 filings.
See up to 3 months of GRDN. The 7-day demo opens the 1M and 3M ranges and puts GRDN on your watchlist.
Start 7-day demoLatest GRDN insider trades
About Guardian Pharmacy Services, Inc. (GRDN)
The SEC lists Guardian Pharmacy Services, Inc. under CIK 0001802255, in drug stores and proprietary stores. We track it alongside the rest of the Consumer Staples sector.
GRDN Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Option exercise | 34 | 49,710,780 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
GRDN insider transactions (Form 4)
5966 Form 4 filings on record, the earliest from Oct 1, 2024, newest first. Filing history page 1 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| William Franklin Mudd - Officer | Option exercise | Class A Common Stock | 38,282 | - footnote F1 | - | |
| William Franklin Mudd - Officer | Option exercise | Class B Common Stock | 38,282 | - footnote F1 | - | |
| ||||||
| Robert Weir - Officer | Option exercise | Class A Common Stock | 23,450 | - footnote F1 | - | |
| Robert Weir - Officer | Option exercise | Class B Common Stock | 23,450 | - footnote F1 | - | |
| ||||||
| John Ackerman - Director | Option exercise | Class A Common Stock | 1,413,939 | - footnote F1 | - | |
| John Ackerman - Director | Option exercise | Class A Common Stock | 471,057 | - footnote F1 | - | |
| John Ackerman - Director | Option exercise | Class B Common Stock | 1,413,939 | - footnote F1 | - | |
| John Ackerman - Director | Option exercise | Class B Common Stock | 471,057 | - footnote F1 | - | |
| ||||||
| Thomas J. Salentine Jr. - Director | Option exercise | Class A Common Stock | 6,100,175 | - footnote F1 | - | |
| Thomas J. Salentine Jr. - Director | Option exercise | Class B Common Stock | 6,100,175 | - footnote F1 | - | |
| ||||||
| David Norman Martin - Officer | Option exercise | Class A Common Stock | 39,865 | - footnote F1 | - | |
| David Norman Martin - Officer | Option exercise | Class B Common Stock | 39,865 | - footnote F1 | - | |
| ||||||
| Pharmacy Investors, LLC | Option exercise | Class A Common Stock | 1,413,939 | - footnote F1 | - | |
| Pharmacy Investors, LLC | Option exercise | Class B Common Stock | 1,413,939 | - footnote F1 | - | |
| ||||||
| Fred Burke - Officer | Option exercise | Class A Common Stock | 1,298,825 | - footnote F1 | - | |
| Fred Burke - Officer | Option exercise | Class B Common Stock | 1,298,825 | - footnote F1 | - | |
| ||||||
| Jeffrey Tuch - Officer | Option exercise | Class A Common Stock | 55,578 | - footnote F1 | - | |
| Jeffrey Tuch - Officer | Option exercise | Class B Common Stock | 55,578 | - footnote F1 | - | |
| ||||||
| Kendall Forbes | Option exercise | Class A Common Stock | 608,570 | - footnote F1 | - | |
| Kendall Forbes | Option exercise | Class B Common Stock | 608,570 | - footnote F1 | - | |
| ||||||
| William E. Bindley - Director | Option exercise | Class A Common Stock | 6,100,175 | - footnote F1 | - | |
| William E. Bindley - Director | Option exercise | Class B Common Stock | 6,100,175 | - footnote F1 | - | |
| ||||||
| David K. Morris - Officer | Option exercise | Class A Common Stock | 641,870 | - footnote F1 | - | |
| David K. Morris - Officer | Option exercise | Class B Common Stock | 641,870 | - footnote F1 | - | |
| ||||||
| Chris Crisafulli - Officer | Option exercise | Class A Common Stock | 18,931 | - footnote F1 | - | |
| Chris Crisafulli - Officer | Option exercise | Class B Common Stock | 18,931 | - footnote F1 | - | |
| ||||||
| Richard Eakins - Officer | Option exercise | Class A Common Stock | 36,052 | - footnote F1 | - | |
| Richard Eakins - Officer | Option exercise | Class B Common Stock | 36,052 | - footnote F1 | - | |
| ||||||
| Cardinal Equity Fund, L.P. | Option exercise | Class A Common Stock | 471,057 | - footnote F1 | - | |
| Cardinal Equity Fund, L.P. | Option exercise | Class B Common Stock | 471,057 | - footnote F1 | - | |
| ||||||
| Bindley Capital Partners I, LLC - 10% Owner | Option exercise | Class A Common Stock | 6,100,175 | - footnote F1 | - | |
| Bindley Capital Partners I, LLC - 10% Owner | Option exercise | Class B Common Stock | 6,100,175 | - footnote F1 | - | |
| ||||||
| Douglas Towns - Officer | Option exercise | Class A Common Stock | 23,450 | - footnote F1 | - | |
| Douglas Towns - Officer | Option exercise | Class B Common Stock | 23,450 | - footnote F1 | - | |
| ||||||
| Grant or award | Class A Common Stock | 4,028 footnote F1 | $0.00 | - | ||
| ||||||
| Randall J. Lewis | Grant or award | Class A Common Stock | 4,028 footnote F1 | $0.00 | - | |
| ||||||
| Mary Sue Patchett | Grant or award | Class A Common Stock | 4,028 footnote F1 | $0.00 | - | |
| ||||||
| Pharmacy Investors, LLC | Option exercise | Class A Common Stock | 1,413,939 | - footnote F1 | - | |
| Pharmacy Investors, LLC | Option exercise | Class B Common Stock | 1,413,939 | - footnote F1 | - | |
| ||||||
| William E. Bindley | Option exercise | Class A Common Stock | 6,100,175 | - footnote F1 | - | |
| William E. Bindley | Option exercise | Class B Common Stock | 6,100,175 | - footnote F1 | - | |
| ||||||
| Kendall Forbes - Officer | Option exercise | Class A Common Stock | 608,570 | - footnote F1 | - | |
| Kendall Forbes - Officer | Option exercise | Class B Common Stock | 608,570 | - footnote F1 | - | |
| ||||||
| Cardinal Equity Fund, L.P. | Option exercise | Class A Common Stock | 471,057 | - footnote F1 | - | |
| Cardinal Equity Fund, L.P. | Option exercise | Class B Common Stock | 471,057 | - footnote F1 | - | |
| ||||||
| David K. Morris - Officer | Option exercise | Class A Common Stock | 641,869 | - footnote F1 | - | |
| David K. Morris - Officer | Option exercise | Class B Common Stock | 641,869 | - footnote F1 | - | |
| ||||||
| Bindley Capital Partners I, LLC | Option exercise | Class A Common Stock | 6,100,175 | - footnote F1 | - | |
| Bindley Capital Partners I, LLC | Option exercise | Class B Common Stock | 6,100,175 | - footnote F1 | - | |
| ||||||
| John Ackerman | Option exercise | Class A Common Stock | 1,413,939 | - footnote F1 | - | |
| John Ackerman | Option exercise | Class A Common Stock | 471,057 | - footnote F1 | - | |
| John Ackerman | Option exercise | Class B Common Stock | 1,413,939 | - footnote F1 | - | |
| John Ackerman | Option exercise | Class B Common Stock | 471,057 | - footnote F1 | - | |
| ||||||
| Thomas J. Salentine Jr. | Option exercise | Class A Common Stock | 6,100,175 | - footnote F1 | - | |
| Thomas J. Salentine Jr. | Option exercise | Class B Common Stock | 6,100,175 | - footnote F1 | - | |
| ||||||
| Fred Burke - Officer | Option exercise | Class A Common Stock | 1,298,826 | - footnote F1 | - | |
| Fred Burke - Officer | Option exercise | Class B Common Stock | 1,298,826 | - footnote F1 | - | |
| ||||||
| Pharmacy Investors, LLC | Open-market sale | Class A Common Stock | 827,636 | $29.68 | $24.57M | |
| David K. Morris - Officer | Open-market sale | Class A Common Stock | 187,855 | $29.68 | $5.58M | |
GRDN insider trading FAQ
What is the latest insider trade for GRDN?
Guardian Pharmacy Services, Inc. (GRDN) had 16 insider filings in the last 90 days, with the most recent on 2026-09-28. The full record for GRDN runs to 66 Form 4 filings, the earliest from 2024-10-01. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying GRDN stock?
No insider purchases of GRDN were filed in the last 90 days. 6 purchases are on record for this company.
How many insiders are selling GRDN stock?
No insider sales of GRDN were filed in the last 90 days. 14 sales are on record for this company.
Where can I see GRDN SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects GRDN Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Consumer Staples companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - William Franklin Mudd view on EDGAR
- - Robert Weir view on EDGAR
- - John Ackerman view on EDGAR
- - Thomas J. Salentine Jr. view on EDGAR
- - David Norman Martin view on EDGAR
- - Pharmacy Investors, LLC view on EDGAR
- - Fred Burke view on EDGAR
- - Jeffrey Tuch view on EDGAR
- - Kendall Forbes view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Consumer Staples
- Where GRDN's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow GRDN with a 7-day demo
- GRDN on your watchlist
- Every GRDN Form 4 filing on record
- Up to 3 months of GRDN price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive